Pediatric Cerebral Venous Sinus Thrombosis: Insights into Risk Profiles, Imaging Features, and Management Outcomes from a Single-Center Cohort
Neurosciences · 30.10.2026 · 31 (4) · 407-414
DOI: 10.17712/1658-3183.2820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosciences, online erschienen am 30.10.2026. Verfasst von Majdah A. Almaghrabi und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To characterize the clinical presentation, risk factors, neuroimaging findings, management strategies, and outcomes of pediatric cerebral venous sinus thrombosis (CVST).
Methods
We retrospectively reviewed electronic medical records of pediatric patients with imaging-confirmed CVST at a tertiary care center in Jeddah, Kingdom of Saudi Arabia. Demographics, clinical features, risk factors, laboratory and imaging findings, management, and outcomes were analyzed. Descriptive statistics, bivariate analyses, and linear regression were performed.
Results
Seventeen patients were included (mean age 4.6 years, 64% male). Altered level of consciousness (58%), seizures (41%), and headache (35%) were the most common presentations. Infection was the predominant risk factor (71%), including sepsis (35%), meningitis (29%), otitis media (18%), and mastoiditis (18%). Extensive or multiple sinus thrombosis occurred in 58% of patients; isolated right transverse sinus thrombosis was most frequent (24%). Anticoagulation was administered to 88% of patients (primarily low-molecular-weight heparin) with no major bleeding complications. Follow-up imaging (35% of patients) showed complete recanalization in 4 and persistent thrombosis in 2. One patient died (5.9% mortality). Infection was significantly associated with altered consciousness (OR 18.0, p = 0.02). Age did not predict extent of sinus involvement (p = 0.44).
Conclusion
Pediatric CVST in this cohort is strongly linked to infection, which frequently presents with altered mental status. Anticoagulation appears safe and well tolerated. Larger prospective studies are needed to standardize treatment protocols and assess long-term neurodevelopmental outcomes.
Zitieren
APA
Almaghrabi, M. A., Althubaiti, F., Algiraigri, A. H., Hammad, R. M., & Khalil, M. (2026). Pediatric Cerebral Venous Sinus Thrombosis: Insights into Risk Profiles, Imaging Features, and Management Outcomes from a Single-Center Cohort. Neurosciences, 31(4), 407-414. https://doi.org/10.17712/1658-3183.2820
Vancouver
Almaghrabi MA, Althubaiti F, Algiraigri AH, Hammad RM, Khalil M. Pediatric Cerebral Venous Sinus Thrombosis: Insights into Risk Profiles, Imaging Features, and Management Outcomes from a Single-Center Cohort. Neurosciences. 2026;31(4):407-414. doi:10.17712/1658-3183.2820
BibTeX
@article{Almaghrabi2026,
author = {Almaghrabi, Majdah A. and Althubaiti, Faris and Algiraigri, Ali H. and Hammad, Rawan M. and Khalil, Mohammad},
title = {Pediatric Cerebral Venous Sinus Thrombosis: Insights into Risk Profiles, Imaging Features, and Management Outcomes from a Single-Center Cohort},
journal = {Neurosciences},
year = {2026},
volume = {31},
number = {4},
pages = {407--414},
doi = {10.17712/1658-3183.2820}
}
EUVIMED